FDA has approved the Edwards Sapien M3 Transcatheter Mitral Valve Replacement System for prohibitive-risk patients with severe mitral regurgitation. This transseptally delivered system offers a true valve replacement option, supported by the ENCIRCLE trial data demonstrating significant MR reduction and improved outcomes. #FDA #MedicalDevice #Cardiology #StructuralHeart #MitralValve TMVR SapienM3 ENCIRCLETrial | Abdallah Othman

This is a quick video showing deployment of the Edwards Lifesciences Sapien 3 Ultra TAVR valve. It is a demo in the virtual trade show section of the SCAI 2020 virtual meeting. Most vendors have posted a short video showing their newest product. #SCAI2020 | Diagnostic and Interventional Cardiology - DAIC